293 related articles for article (PubMed ID: 22423162)
1. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010.
Zignol M; van Gemert W; Falzon D; Sismanidis C; Glaziou P; Floyd K; Raviglione M
Bull World Health Organ; 2012 Feb; 90(2):111-119D. PubMed ID: 22423162
[TBL] [Abstract][Full Text] [Related]
2. Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data.
Zignol M; Dara M; Dean AS; Falzon D; Dadu A; Kremer K; Hoffmann H; Hoffner S; Floyd K
Drug Resist Updat; 2013 Dec; 16(6):108-15. PubMed ID: 24631052
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance.
Wright A; Zignol M; Van Deun A; Falzon D; Gerdes SR; Feldman K; Hoffner S; Drobniewski F; Barrera L; van Soolingen D; Boulabhal F; Paramasivan CN; Kam KM; Mitarai S; Nunn P; Raviglione M;
Lancet; 2009 May; 373(9678):1861-73. PubMed ID: 19375159
[TBL] [Abstract][Full Text] [Related]
4. On the spread and control of MDR-TB epidemics: an examination of trends in anti-tuberculosis drug resistance surveillance data.
Cohen T; Jenkins HE; Lu C; McLaughlin M; Floyd K; Zignol M
Drug Resist Updat; 2014; 17(4-6):105-23. PubMed ID: 25458783
[TBL] [Abstract][Full Text] [Related]
5. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.
Espinal MA; Kim SJ; Suarez PG; Kam KM; Khomenko AG; Migliori GB; Baéz J; Kochi A; Dye C; Raviglione MC
JAMA; 2000 May; 283(19):2537-45. PubMed ID: 10815117
[TBL] [Abstract][Full Text] [Related]
6. [Multiple drug resistance: a threat for tuberculosis control].
Cardoso EM
Rev Panam Salud Publica; 2004 Jul; 16(1):68-73. PubMed ID: 15333267
[TBL] [Abstract][Full Text] [Related]
7. Childhood multidrug-resistant tuberculosis in the European Union and European Economic Area: an analysis of tuberculosis surveillance data from 2007 to 2015.
Ködmön C; van den Boom M; Zucs P; van der Werf MJ
Euro Surveill; 2017 Nov; 22(47):. PubMed ID: 29183553
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995.
Liu Z; Shilkret KL; Finelli L
Int J Epidemiol; 1998 Feb; 27(1):121-6. PubMed ID: 9563705
[TBL] [Abstract][Full Text] [Related]
9. Multidrug-resistant tuberculosis in children: evidence from global surveillance.
Zignol M; Sismanidis C; Falzon D; Glaziou P; Dara M; Floyd K
Eur Respir J; 2013 Sep; 42(3):701-7. PubMed ID: 23222872
[TBL] [Abstract][Full Text] [Related]
10. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011.
Ulmasova DJ; Uzakova G; Tillyashayhov MN; Turaev L; van Gemert W; Hoffmann H; Zignol M; Kremer K; Gombogaram T; Gadoev J; du Cros P; Muslimova N; Jalolov A; Dadu A; de Colombani P; Telnov O; Slizkiy A; Kholikulov B; Dara M; Falzon D
Euro Surveill; 2013 Oct; 18(42):. PubMed ID: 24176581
[TBL] [Abstract][Full Text] [Related]
11. Drug-resistant tuberculosis in the WHO Western Pacific Region.
Islam T; Hiatt T; Hennig C; Nishikiori N
Western Pac Surveill Response J; 2014; 5(4):34-46. PubMed ID: 25685604
[TBL] [Abstract][Full Text] [Related]
12. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
[TBL] [Abstract][Full Text] [Related]
13. Proportions and Risk Factors of Developing Multidrug Resistance Among Patients with Tuberculosis in China: A Population-Based Case-Control Study.
Huai P; Huang X; Cheng J; Zhang C; Wang K; Wang X; Yang L; Deng Z; Ma W
Microb Drug Resist; 2016 Dec; 22(8):717-726. PubMed ID: 27058017
[TBL] [Abstract][Full Text] [Related]
14. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
van Maaren PJ
Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistant tuberculosis: trends and control.
Prasad R; Gupta N; Singh M
Indian J Chest Dis Allied Sci; 2014; 56(4):237-46. PubMed ID: 25962197
[TBL] [Abstract][Full Text] [Related]
16. Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design.
Mok JH; Kang BH; Lee T; Lee HK; Jang HJ; Cho YJ; Jeon D
J Korean Med Sci; 2017 Apr; 32(4):636-641. PubMed ID: 28244290
[TBL] [Abstract][Full Text] [Related]
17. Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country.
Jenkins HE; Plesca V; Ciobanu A; Crudu V; Galusca I; Soltan V; Serbulenco A; Zignol M; Dadu A; Dara M; Cohen T
Eur Respir J; 2013 Nov; 42(5):1291-301. PubMed ID: 23100496
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana.
Tembo BP; Malangu NG
BMC Infect Dis; 2019 Sep; 19(1):779. PubMed ID: 31492099
[TBL] [Abstract][Full Text] [Related]
19. Trends in drug-resistant tuberculosis in the United States, 1993-1996.
Moore M; Onorato IM; McCray E; Castro KG
JAMA; 1997 Sep; 278(10):833-7. PubMed ID: 9293991
[TBL] [Abstract][Full Text] [Related]
20. Multidrug-resistant tuberculosis around the world: what progress has been made?
Falzon D; Mirzayev F; Wares F; Baena IG; Zignol M; Linh N; Weyer K; Jaramillo E; Floyd K; Raviglione M
Eur Respir J; 2015 Jan; 45(1):150-60. PubMed ID: 25261327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
